Anemia Impacts on Clinical Outcomes in Acute Ischemic Stroke

Anemia at the time of acute ischemic stroke is increasingly recognised as a key modifier of clinical trajectory. Reduced haemoglobin concentration limits oxygen delivery to the ischaemic penumbra, exacerbating neuronal injury and accelerating infarct growth. Observational evidence demonstrates that even modest reductions in haemoglobin on admission correlate with larger final lesion volumes, higher in-hospital mortality and poorer functional recovery at three months. The relationship is not strictly linear: both low and unusually high haemoglobin levels have been associated with increased mortality, suggesting a U-shaped risk curve. Anemia also interacts with established prognostic indicators such as stroke severity and comorbidity burden, amplifying adverse outcomes across diverse health systems. Despite its prevalence—affecting up to 40% of patients with acute ischaemic stroke—optimal strategies for detection and management of peri-stroke anaemia, including transfusion thresholds, remain undefined. Addressing this gap has global implications for resource allocation, guideline development and the design of targeted interventions to improve survival and long-term independence.

Research from Nature Portfolio

A seminal meta-analysis of cohort studies pooled data from nearly 20 000 stroke patients to assess the prognostic impact of anaemia. It found that reduced haemoglobin on admission was associated with a 39% increase in adjusted mortality risk. Subgroup and sensitivity analyses confirmed the robustness of this finding across age groups, stroke subtypes and geographic settings. The study highlights haemoglobin concentration as an independent predictor of survival and underscores the need for prospective trials to define haemoglobin targets in acute stroke management.

Anemia Impacts on Clinical Outcomes in Acute Ischemic Stroke publication trend

The graph below shows the total number of articles in anemia impacts on clinical outcomes in acute ischemic stroke across all publications each year (not limited to Nature Index journals).

Technical terms

Anaemia: A condition in which haemoglobin concentration falls below normal thresholds, reducing the blood’s oxygen-carrying capacity.

Haemoglobin: The iron-containing protein in red blood cells responsible for oxygen transport from lungs to tissues.

Infarct volume: The total area of brain tissue irreversibly damaged by ischaemia, typically measured by imaging.

Modified Rankin Scale: A scale from 0 to 6 that quantifies the degree of disability or dependence in daily activities after stroke.

National Institutes of Health Stroke Scale (NIHSS): A standardized tool to assess neurological deficit severity in stroke patients.

Thrombolysis: The pharmacological dissolution of a blood clot using agents such as tissue-type plasminogen activator.

Endovascular therapy: Mechanical removal or disruption of a thrombus via catheter-based intervention within cerebral arteries.

References

1. Exploring Relationships of Heart Rate Variability, Neurological Function, and Clinical Factors with Mortality and Behavioral Functional Outcome in Patients with Ischemic Stroke. Diagnostics (2024).
2. Anemia increases the mortality risk in patients with stroke: A meta-analysis of cohort studies. Scientific Reports (2016).
3. Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome. PLOS ONE (2018).
4. Impact of anemia on acute ischemic stroke outcomes: A systematic review of the literature. PLOS ONE (2023).